20 Volunteers Suffer Serious Reactions to Johnson & Johnson’s COVID-19 Vaccine

20 Volunteers Suffer Serious Reactions to Johnson & Johnson’s COVID-19 Vaccine

On Sept. 23, 2020, U.S. pharmaceutical and medical devices company Johnson & Johnson, Inc. announced the start of the Phase 3 human clinical trial for its experimental Ad26.COV2.S vaccine for COVID-19. The New Jersey-based company, which is partnering with its subsidiary Janssen Pharmaceutica NV of Belgium on development of the vaccine, is planning to enroll […]